JACC:性活动与心肌梗死无相关性

2015-09-29 徐媛 MedSci原创

据一项发表在《美国心脏病学会杂志》报告显示,性活动与心肌梗死发病率增加没有相关性,心梗后患者的性活动是安全。在这项前瞻性队列研究中,研究人员收纳了冠心病(CHD)相关心梗后参与了住院患者康复项目的患者536名,年龄在30到70岁,平均年龄57岁,85.8%都是男性。通过标准化的问卷对心梗前12个月内的性活动进行评估。相对总体而言,在评估期间55%的参与者报告每周至少1次性活动,25.4%报告每周少

据一项发表在《美国心脏病学会杂志》报告显示,性活动与心肌梗死发病率增加没有相关性,心梗后患者的性活动是安全。

在这项前瞻性队列研究中,研究人员收纳了冠心病(CHD)相关心梗后参与了住院患者康复项目的患者536名,年龄在30到70岁,平均年龄57岁,85.8%都是男性。通过标准化的问卷对心梗前12个月内的性活动进行评估。相对总体而言,在评估期间55%的参与者报告每周至少1次性活动,25.4%报告每周少于1次,4.7%报告每月少于1次,14.9%报告无性活动。

在10年的随访期间,共发生100次心血管相关事件(整体事件发生率,每年23.9/1000人)。与每周少于1次性活动的患者相比,性活动频率较高的患者心血管事件发病风险较低(HR = 0.49; 95% CI, 0.31-0.77)。438名患者报告了心梗前最后一次性活动的时间,其中0.7%的患者为心梗前1小时内,1.5%的患者为心梗前3-6小时,多余78%的患者为心梗前24小时以上。

Dietrich Rothenbacher教授指出,根据以上数据,性活动可能不是引发心脏病的因素。

“当前美国指南建议,患者在非复杂性心梗后1周以上,如果进行轻中度体力活动时无心脏症状,则可以恢复性生活。”

原始出处

Dietrich Rothenbacher, MD, MPH; Dhayana Dallmeier, MD, PhD; Ute Mons, MA, PhD; Wayne Rosamond, PhD; Wolfgang Koenig, MD; Hermann Brenner, MD, MPH.Sexual Activity Patterns Before Myocardial Infarction and Risk of Subsequent Cardiovascular Adverse Events.J Am Coll Cardiol. 2015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1853417, encodeId=a08f185341ea8, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Dec 30 21:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837168, encodeId=9f3f183e16858, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Apr 02 17:44:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037030, encodeId=c704203e030af, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Mon Aug 01 03:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37842, encodeId=f7433e84264, content=哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151007/IMG5614DFD08DD5E9130.jpg, createdBy=73c61625379, createdName=飞马, createdTime=Wed Oct 07 17:02:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37724, encodeId=9b1c3e724ec, content=哦哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Oct 05 21:13:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325111, encodeId=a3b413251114e, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Oct 01 02:44:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37584, encodeId=e78e3e5846b, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3911653185, createdName=1ddd0b24m59(暂无匿称), createdTime=Wed Sep 30 15:07:00 CST 2015, time=2015-09-30, status=1, ipAttribution=)]
    2015-12-30 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1853417, encodeId=a08f185341ea8, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Dec 30 21:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837168, encodeId=9f3f183e16858, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Apr 02 17:44:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037030, encodeId=c704203e030af, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Mon Aug 01 03:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37842, encodeId=f7433e84264, content=哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151007/IMG5614DFD08DD5E9130.jpg, createdBy=73c61625379, createdName=飞马, createdTime=Wed Oct 07 17:02:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37724, encodeId=9b1c3e724ec, content=哦哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Oct 05 21:13:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325111, encodeId=a3b413251114e, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Oct 01 02:44:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37584, encodeId=e78e3e5846b, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3911653185, createdName=1ddd0b24m59(暂无匿称), createdTime=Wed Sep 30 15:07:00 CST 2015, time=2015-09-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1853417, encodeId=a08f185341ea8, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Dec 30 21:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837168, encodeId=9f3f183e16858, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Apr 02 17:44:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037030, encodeId=c704203e030af, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Mon Aug 01 03:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37842, encodeId=f7433e84264, content=哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151007/IMG5614DFD08DD5E9130.jpg, createdBy=73c61625379, createdName=飞马, createdTime=Wed Oct 07 17:02:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37724, encodeId=9b1c3e724ec, content=哦哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Oct 05 21:13:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325111, encodeId=a3b413251114e, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Oct 01 02:44:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37584, encodeId=e78e3e5846b, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3911653185, createdName=1ddd0b24m59(暂无匿称), createdTime=Wed Sep 30 15:07:00 CST 2015, time=2015-09-30, status=1, ipAttribution=)]
    2016-08-01 fyxzlh
  4. [GetPortalCommentsPageByObjectIdResponse(id=1853417, encodeId=a08f185341ea8, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Dec 30 21:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837168, encodeId=9f3f183e16858, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Apr 02 17:44:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037030, encodeId=c704203e030af, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Mon Aug 01 03:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37842, encodeId=f7433e84264, content=哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151007/IMG5614DFD08DD5E9130.jpg, createdBy=73c61625379, createdName=飞马, createdTime=Wed Oct 07 17:02:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37724, encodeId=9b1c3e724ec, content=哦哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Oct 05 21:13:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325111, encodeId=a3b413251114e, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Oct 01 02:44:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37584, encodeId=e78e3e5846b, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3911653185, createdName=1ddd0b24m59(暂无匿称), createdTime=Wed Sep 30 15:07:00 CST 2015, time=2015-09-30, status=1, ipAttribution=)]
    2015-10-07 飞马

    哈哈

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1853417, encodeId=a08f185341ea8, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Dec 30 21:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837168, encodeId=9f3f183e16858, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Apr 02 17:44:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037030, encodeId=c704203e030af, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Mon Aug 01 03:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37842, encodeId=f7433e84264, content=哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151007/IMG5614DFD08DD5E9130.jpg, createdBy=73c61625379, createdName=飞马, createdTime=Wed Oct 07 17:02:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37724, encodeId=9b1c3e724ec, content=哦哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Oct 05 21:13:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325111, encodeId=a3b413251114e, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Oct 01 02:44:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37584, encodeId=e78e3e5846b, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3911653185, createdName=1ddd0b24m59(暂无匿称), createdTime=Wed Sep 30 15:07:00 CST 2015, time=2015-09-30, status=1, ipAttribution=)]
    2015-10-05 sanshengshi

    哦哦

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1853417, encodeId=a08f185341ea8, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Dec 30 21:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837168, encodeId=9f3f183e16858, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Apr 02 17:44:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037030, encodeId=c704203e030af, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Mon Aug 01 03:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37842, encodeId=f7433e84264, content=哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151007/IMG5614DFD08DD5E9130.jpg, createdBy=73c61625379, createdName=飞马, createdTime=Wed Oct 07 17:02:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37724, encodeId=9b1c3e724ec, content=哦哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Oct 05 21:13:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325111, encodeId=a3b413251114e, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Oct 01 02:44:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37584, encodeId=e78e3e5846b, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3911653185, createdName=1ddd0b24m59(暂无匿称), createdTime=Wed Sep 30 15:07:00 CST 2015, time=2015-09-30, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1853417, encodeId=a08f185341ea8, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Dec 30 21:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837168, encodeId=9f3f183e16858, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Apr 02 17:44:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037030, encodeId=c704203e030af, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Mon Aug 01 03:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37842, encodeId=f7433e84264, content=哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151007/IMG5614DFD08DD5E9130.jpg, createdBy=73c61625379, createdName=飞马, createdTime=Wed Oct 07 17:02:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37724, encodeId=9b1c3e724ec, content=哦哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Mon Oct 05 21:13:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325111, encodeId=a3b413251114e, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Oct 01 02:44:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37584, encodeId=e78e3e5846b, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3911653185, createdName=1ddd0b24m59(暂无匿称), createdTime=Wed Sep 30 15:07:00 CST 2015, time=2015-09-30, status=1, ipAttribution=)]
    2015-09-30 1ddd0b24m59(暂无匿称)

    好学习了

    0

相关资讯

JACC:老年房颤患者急性心肌梗死的三联疗法的应用及疗效

    抗血栓治疗对于经皮冠状动脉介入治疗(PCI)治疗的风险较高的心房颤动(AF)老年患者的急性心肌梗死(MI)效果仍不清楚。    这项研究旨在确定适当的抗血栓治疗方法治疗通过PCI治疗房颤的急性MI患者。    研究人员对4,959例≥65岁的急性MI和AF并接受冠状动脉支架置入术(急性冠脉综合治疗及干预结果网络登记处)患者进行了研

心肌梗死后心脏破裂

1 影响因素心肌梗死后心脏破裂高特异性和高敏感性的危险预测因素至今仍缺乏。ST段抬高、ST段偏移、女性、卒中史、初始心肌标志物阳性、高龄、心率快、收缩压降低,延迟溶栓治疗等被证实为危险因素;而心肌梗死病史、发病后24h内使用低分子肝素和β受体阻滞剂被认为是保护因素。一项入选了2800例ST段抬高型心肌梗死行直接经皮冠状动脉介入治疗(percutaneous coronary intervent

BMJ Open:抗癫痫药与缺血性卒中和心肌梗死发生的关系

目的:肝酶诱导的抗癫痫药物(AEDs)通过诱导细胞色素P450增加血浆中的脂质及其他动脉粥样硬化标志物,因此可能会增加血管事件的发生。研究人员根据AED代谢的酶特性旨在评估其对缺血性卒中和心肌梗死(MI)发生的风险。设计:病例对照分析的群体队列研究。英国临床实践研究数据链中的650个普通医生的医业。受试者:招募1990年1月到2013年4月间252407名应用AED的患者,患者年龄在18岁以上。每

J Alzheimers Dis: AD患者‪发生心血管事件30天后死亡率

背景和目的:患有阿尔茨海默的患者(AD)并未得到标准的治疗。研究人员研究了AD患者或非AD患者缺血性卒中,出血性卒中或者心肌梗死后30年的死亡率。方法:选取2005-2012年间,芬兰社区居民诊断为AD的患者(n=73005)以及1-4配对的对照组人群/AD影响的人群(n=215449)进行配对研究。从国家医院出院记录中获得缺血性卒中(n=16419;死亡:2748);出血性卒中(n=3570;死

J Cardiol:尿石症患者增加心血管事件的发生

背景:尽管许多证据表明尿石症患者增加心血管疾病(CVD)的发生,但是尿石症与CVD事件发生的关系的纵向性研究较少。研究人员调查台湾人群队列数据库中,患有尿石症患者和心肌梗塞(MI)或卒中发生的相关性。方法:研究人员在台湾国家健康保险研究数据库随机抽取100万人的信息进行分析。81536名年龄在18岁及以上患者,在研究期间40773名患者诊断为尿石症,选取相匹配的40773名无尿石症的患者作为对照。